Results 81 to 90 of about 9,759 (160)

Metabolic reprogramming in tumor-associated cells of hematologic malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment. [PDF]

Front Immunol
Hong Z, Wu Y, Liu W, Li D, Xu J.
europepmc   +1 more source

Lysophosphatidic acid-mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development. [PDF]

J Clin Invest
Yasuda D, Sato N, Yanagida K, Hashidate-Yoshida T, Shiiya T, Shindou H, Taira A, Ebihara T, Shimizu T, Hirashima M, Mizuno S, Takahashi S, Ishii S.   +12 more
europepmc   +1 more source

New and emerging treatments for PBC-related pruritus. [PDF]

Drugs Context
Anderson SL.
europepmc   +1 more source

The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma. [PDF]

J Cell Mol Med
Caniceiro AB, Agostinho SP, Piochi LF, Rosário-Ferreira N, Moreira IS.   +4 more
europepmc   +1 more source

Lpar3-mediated macrophage polarization promotes inflammatory tooth extraction socket healing and alveolar bone regeneration. [PDF]

Regen Ther
Zhang N, Ji S, He Z, Wu D.
europepmc   +1 more source

Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis. [PDF]

JHEP Rep
Wang X, Wang J, Xiong L, Tang S, Wu S, Zhao J, Wang Z, Zhu J, Li Y, Zhuang J, Wu J, Zhang J, Zhou Z, Huang J, Shen H, Wu M, Qi L, He W, Hu R, Turner JR, Huang Y, Wang H, Zuo L.   +22 more
europepmc   +1 more source

Targeting Phosphoinositide 3-Kinase to Reduce the Progression of Ovarian Cancer Cells in a 3D Collagen Model. [PDF]

Biomolecules
Tino AB, Sykes PH, Dachs GU, Chitcholtan K.   +3 more
europepmc   +1 more source

Role of Autotaxin in the Pathogenesis of Retina Ischemia and Its Therapeutic Implications. [PDF]

Int J Mol Sci
Terao R, Fujino R, Hayashi K, Suzuki T, Shimizu S, Yamagishi R, Ueta T, Shiraya T, Honjo M, Aihara M.   +9 more
europepmc   +1 more source

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist
Lysophosphatidic acid (LPA) is a pluripotent lipid mediator acting through plasma membrane-associated LPAx receptors that transduce many, but not all, of its effects. We identify peroxisome proliferator-activated receptor γ (PPARγ) as an intracellular receptor for LPA.
openaire  

Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. [PDF]

Med Rev (2021)
Yang J, Xiao H, Zhang Z, Zhang L, Zhang X.   +4 more
europepmc   +1 more source